We therefore used marker genes in cluster 9 to develop a “fibrogenic profile,” which included pathways such as hepatic fibrosis signaling, actin cytoskeleton signaling, Tgfb signaling, and inhibition of matrix metalloproteinases (Figure 4A). The gene discussed is TGFB1; the disease is Hepatic fibrosis.